# Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders

> **NCT00008307** · PHASE2 · UNKNOWN · sponsor: **Herbert Irving Comprehensive Cancer Center** · enrollment: 52 (estimated)

## Conditions studied

- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes

## Interventions

- **BIOLOGICAL:** anti-thymocyte globulin
- **DRUG:** cyclosporine
- **DRUG:** fludarabine phosphate
- **DRUG:** melphalan
- **DRUG:** methylprednisolone
- **DRUG:** mycophenolate mofetil
- **PROCEDURE:** allogeneic bone marrow transplantation
- **PROCEDURE:** peripheral blood stem cell transplantation
- **PROCEDURE:** syngeneic bone marrow transplantation

## Key facts

- **NCT ID:** NCT00008307
- **Lead sponsor:** Herbert Irving Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2014-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00008307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00008307, "Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00008307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*